Carlo Alfieri: Redefining Anemia Management After Kidney Transplantation
Carlo Alfieri, Editor-in-Chief of GCND, Associate Professor at the University of Milan., shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in GCND, adding:
“I am pleased to share our latest publication in the Journal of Clinical Nephrology and Dialysis:
‘Rethinking Anemia Management After Kidney Transplant’
Post-transplant anemia remains one of the most frequent and clinically relevant complications after kidney transplantation, with important implications for graft function, cardiovascular risk, and patient survival. In this review, we provide an updated overview of its pathophysiology and current therapeutic strategies, with particular attention to the emerging role of HIF-prolyl hydroxylase inhibitors (HIF-PHIs) in the management of kidney transplant recipients.
As editor in chief of the journal, I am committed to promoting high-quality scientific research and stimulating discussion on clinically relevant topics in nephrology and transplantation.
I warmly encourage colleagues to consider GCND for the submission of their original articles, reviews, short communications, and clinical experiences, helping to further strengthen our scientific community.”
Title: From iron to HIF-PH inhibitors: rethinking anemia management after kidney transplant
Authors: Anna De Amici, Chiara De Liso, Anna Pisacreta, Margherita Di Naro, Lara Caldiroli, Paolo Molinari, Anna Regalia, Emilietta Brigati, Simona Verdesca, Marco Maggi, Matteo Tommaso Righi, Michele Filippi, Giuseppe Castellano, Carlo Alfieri
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters